Literature DB >> 51007

Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.

T K Eisenstein.   

Abstract

The nature of the protective substance in ribosomal ribonucleic acid and protein extracts of Salmonella has been investigated. The results of experiments in which vaccines were prepared from isogenic strains and strains with defects in lipopolysaccharide synthesis show that O antigens contaminate both ribonucleic acid and protein ribosomal extracts, and are responsible for at least part of their strain-specific protective activity. In addition, it was observed that a ribosomal ribonucleic acid preparation from S. adelaide contains a heat-stable immunogen which is not an O antigen or that gives cross-protection across species lines. The contribution of ribosomes to the immunity induced by "ribosomal vaccines" is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51007      PMCID: PMC415293          DOI: 10.1128/iai.12.2.364-377.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Extraction of nucleic acid-free lipopolysaccharides from gram-negative bacteria.

Authors:  G J O'NEILL; J P TODD
Journal:  Nature       Date:  1961-04-22       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Non-smooth mutants of Salmonella typhimurium: differentiation by phage sensitivity and genetic mapping.

Authors:  R G Wilkinson; P Gemski; B A Stocker
Journal:  J Gen Microbiol       Date:  1972-05

4.  Lipid A: chemical structure and biological activity.

Authors:  O Lüderitz; C Galanos; V Lehmann; M Nurminen; E T Rietschel; G Rosenfelder; M Simon; O Westphal
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

Review 5.  Structure and synthesis of the ribosomal ribonucleic acid of prokaryotes.

Authors:  N R Pace
Journal:  Bacteriol Rev       Date:  1973-12

6.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

7.  IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

8.  Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

9.  Studies on hemagglutination and hemolysis by escherichia coli antisera.

Authors:  E NETER; L F BERTRAM; D A ZAK; M R MURDOCK; C E ARBESMAN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

10.  SEPARATION, CHARACTERIZATION, AND BIOLOGICAL SIGNIFICANCE OF A COMMON ANTIGEN IN ENTEROBACTERIACEAE.

Authors:  C M KUNIN
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

View more
  43 in total

1.  Complementary methodologies to identify specific agrobacterium strains.

Authors:  H Bouzar; L W Moore
Journal:  Appl Environ Microbiol       Date:  1987-11       Impact factor: 4.792

2.  Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant.

Authors:  D Robert; J P Quillon; B Ivanoff; Y Beaudry; R Fontanges; G Normier; A M Pinel; L D D'hinterland
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

3.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

4.  Salmonella serotype determination utilizing high-throughput genome sequencing data.

Authors:  Shaokang Zhang; Yanlong Yin; Marcus B Jones; Zhenzhen Zhang; Brooke L Deatherage Kaiser; Blake A Dinsmore; Collette Fitzgerald; Patricia I Fields; Xiangyu Deng
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

5.  Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

6.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

8.  Induction of immunoenhancing factors for murine splenocyte cultures by Salmonella typhimurium ribosome and ribonucleic acid extracts.

Authors:  R C Butler; H Friedman; S C Specter; T K Eisenstein
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

9.  Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.

Authors:  S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

10.  Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.